Objective: The objectives of this study were (1) to develop a novel magnetization transfer ratio (MTR) MRI assay of the proximal sciatic nerve (SN), which is inaccessible via current tools for assessing peripheral nerves, and (2) to evaluate the resulting MTR values as a potential biomarker of myelin content changes in patients with Charcot-Marie-Tooth (CMT) diseases.
Charcot-Marie-Tooth (CMT) diseases are a group of inherited neuropathies that affect motor and sensory nerves. A majority of CMT phenotypes can be classified as primary demyelination/dysmyelinating (CMT1) or primary axonal (CMT2) neuropathies. 1, 2 CMT type 1A (CMT1A z 80% of CMT1 cases 3, 4 ) arises from duplication of the peripheral myelin protein 22 (PMP22) gene 5, 6 and results in dysmyelination and secondary axonal loss. 7 CMT type 2A (CMT2A z 35% of CMT2 cases 8 ) is caused by missense mutations in the gene that encodes for mitofusin 2 9 and leads to primary axonal degeneration. 8 Although the pathologic features of CMT1A/CMT2A are different, length-dependent axonal loss occurs in both and is predictive of outcomes. 10 Current tools for assessing patients with CMT include nerve conduction studies (NCS), skin biopsies, 11 and CMT neuropathy scores (CMTNS). 10 These techniques are typically limited to the study of distal nerves, which are often severely damaged and, therefore, unavailable for these tests. Due in part to this limitation, recent CMT1A clinical trials 12, 13 noted difficulty in detecting disease progression when using CMTNS as an outcome measure. In addition, quality of life assessments have shown little sensitivity to disease progression. 14 Proximal nerves are partially preserved in patients with CMT, and may be an ideal target for tracking disease progression and treatment response. Although these nerves are inaccessible via current tools, certain MRI techniques may be suited for probing proximal nerves. For example, MRI of muscle [15] [16] [17] is sensitive to the downstream effects of nerve denervation on muscle. Nerve pathology can also be probed directly via quantitative MRI techniques. For example, diffusion MRI of peripheral nerves yields metrics that relate to disability 18, 19 ; however, this method often requires longer, lower resolution acquisitions than desired. Similar to diffusion MRI, magnetization transfer ratio (MTR) imaging is sensitive to changes in myelin density that can occur from demyelination or axonal loss, 20 and fast, high-resolution MTR imaging of peripheral nerves is feasible. 21 Therefore, we have developed and tested a novel MTR assay of the sciatic nerve (SN) as a potential biomarker in patients with CMT.
METHODS Human subjects and clinical information.
MRI was performed on 21 healthy volunteers with no known history of peripheral neuropathy (control subjects) and 16 patients with a genetically confirmed inherited neuropathy (10 CMT1A, 3 CMT2A, and 3 hereditary neuropathy with liability to pressure palsies [HNPP]). Data were also collected from 4 patients with CMT with unknown genetic causes, but who were diagnosed based on family/clinical history and NCS. Patients were recruited from the Vanderbilt University CMT Clinic, which is part of the international CMT Consortium. No patient had a history of diabetes, renal failure, HIV infection, or other conditions linked to peripheral neuropathies. The span of ages and body mass indices (BMIs) in the control subjects approximately matched the span of values in patients with CMT (table) . A subset of participants was evaluated using the non-NCS portion of the CMT neuropathy score protocol, as previously described. 22 The score is referred to the clinical CMT neuropathy score (CMTNS C ) and is composed of scored evaluations (range 0-4) of sensory and motor symptoms in limbs, pin and vibration sensitivity, and limb muscle strength (CMTNS C range 0-28; higher scores indicate increased impairment). The portion of the CMTNS C taken from the legs (CMTNS L range 0-20) was also extracted for comparison to the MRI measures obtained in the legs.
Motor NCS data were acquired from the median or ulnar nerve of a majority of patients using conventional methods. 23 These data were acquired in the arms because NCS are often nonresponsive in the legs of patients with CMT. 24, 25 Recording electrodes were placed over the bellies of hand thenar and hypothenar muscles, reference electrodes were placed over the tendons at the wrist, and stimulation was performed at the wrist distally and elbow proximally. The mean motor conduction velocity (MCV) and compound motor action potential (CMAP) are reported in the table.
Standard protocol approvals, registrations, and patient consents. Our local institutional review board approved this study, and signed consent was obtained prior to all examinations. MTR data acquisition. MRI was performed using a 3.0T
Philips Achieva MRI scanner (Philips Healthcare, Best, the Netherlands) and a 16-channel torso receive coil. MRI data were collected from a transverse volume in one thigh (figure 1). To measure MTR, multishot echoplanar imaging volumes were acquired with (magnetization transfer [MT]-weighted) and without (reference) application of an MT saturation pulse. 26 The MT pulse parameters were 25-ms single-lobe sinc pulse with Gaussian apodization, 1000°nominal flip angle, and 1.5 kHz off-resonance. Additional parameters included acquired/ reconstructed resolution 5 0.8 3 0.8 3 6 mm 3 /0.75 3 0.75 3 3 mm 3 , field of view 5 192 3 192 3 144 mm 3 , repetition time/echo time/excitation flip angle 5 60 ms/11 ms/10°, k-space lines per shot 5 5, SENSE factor 5 1, signal acquisitions averaged 5 2, and scan time z6 minutes. To minimize bias from fat near the nerve, a water-selective excitation pulse was employed. Previous work 27 demonstrated that large transmit radiofrequency, or B 1 , variations in thigh skeletal muscle bias MTR values in an approximately linear fashion; therefore, we measured B 1 in the same volume as the MTR data using the actual flip-angle imaging approach. 28 MTR data analysis. Data analyses were performed in MAT-LAB (Mathworks, Natick, MA) unless otherwise noted. When motion was detected, MIPAV's (NIH, Bethesda, MD) nonrigid registration tools were applied. 29 Following registration, MTR was calculated as follows:
where S MT and S REF are the signal intensities in the MT-weighted and reference volumes, respectively-we use percent units (pu) instead of % to minimize ambiguity when talking about relative changes. B 1 was estimated 28 and the MTR values were corrected for B 1 variations as previously described. 27 Artifacts corrupted the B 1 correction scheme in 2 subjects. In these subjects, the change in MTR postcorrection was set to the overall median value to minimize bias from these artifacts.
Regions of interest (ROIs) were manually selected for the SN in the 40 central slices of the reference volume. These ROIs were then multiplied by mask generated using MIPAV's segmentation algorithm (fuzzy C-means), which eliminated background voxels as well as voxels that had been partially volume averaged with fat. Mean MTR values were calculated for each slice (MTR s ) and across the entire volume (MTR v ). The mean cross-sectional area of the SN (CSA SN ) was also estimated by multiplying the number of voxels in the ROI by the voxel's cross-sectional area. This was converted to an approximate diameter using the following:
where D SN is the diameter of the SN.
Repeatability studies. To assess interscan reliability, 6 control subjects underwent a second MRI at least 4 weeks after the first session. Inter-rater reliability was estimated in a subset of subjects (6 controls, 4 CMT1A, and 3 CTM2A) by having 2 raters (R.D.D. and L.M.D.) define ROIs as described above.
Statistics. Statistical analyses were performed using STATA/IC 13.1 (StataCorp, College Station, TX). Tests were performed to evaluate (1) the relationship between MTR and confounding variables, (2) the variation of MTR across cohorts, (3) the relationship between MTR and disability, and (4) the repeatability of MTR. Significance was defined at the a 5 0.05 level for all tests.
We first examined the potential confounding influence of BMI, age, and sex on MTR v via multiple linear regression in controls-a Shapiro-Wilk test on the regression residuals suggested normality (p 5 0.81); therefore, parametric statistical tests were used throughout. The effects of BMI, age, and sex on MTR v were quantified via Pearson partial correlation coefficients and were not significant in controls.
Assuming these results are translatable to the patient cohorts, we did not control for these factors in patients and a single-factor analysis of variance was employed to test for variation in MTR v across cohorts. To test for significant differences between cohort pairs, post hoc analysis was performed using a Bonferroni multiple comparison test. Finally, correlations between MTR v and disability scores were evaluated using linear regression analyses (with and without inclusion of the patients with unknown genetic causes) and Pearson correlation coefficients reported.
To understand the ability of MTR to provide estimates of treatment efficacy or disease evolution, it is important to understand the reliability of the acquisition (interscan) and assessment (inter-rater) methodology. To estimate the interscan reliability, intraclass correlation coefficients (ICC) were calculated for MTR s and MTR v . To test for changes in MTR s and MTR v across time, paired t tests were performed between each timepoint. Finally, the interscan variabilities of MTR s and MTR v were estimated via the repeatability coefficient (RC), which is defined as 1.96 times the SD of the mean difference in MTR between scans. Analogous analyses were performed for the inter-rater data. 30 were also studied. Patients with HNPP reported transient, asymmetric, focal sensory loss and weakness following mechanical stresses; conduction velocities (37.7 6 3.5 m/s) were between the values observed in CMT1A and control cohorts. Finally, patients with CMT with unknown genetic causes demonstrated the aforementioned symptoms and family history consistent with CMT as well as slowed conduction velocities (34.8 6 8.1 m/s). Together, these results suggest that the patients studied represent typical populations of each disease.
RESULTS
General features of sciatic nerve MRI. Figure 1 shows sample coronal T 1 -weighted scout images (left), axial MT data from each cohort (right), and user-defined ROIs (red overlay). The most proximal (blue line) and distal slices (green line) from the MT volume are shown. The SN was readily distinguished from surrounding fat (appears dark due to water-selective excitation pulse), muscle, and blood vessels in the proximal slices. Moving distally, the branching of the SN into the tibial and common peroneal nerves is evident. When defining the ROIs, both branches were labeled as SN. Consistent with previous work, 31 nerve hypertrophy was observed in the SN of patients with CMT1A (D SN 5 7.2 6 0.9 mm, table). In contrast, mean nerve sizes in patients with CMT2A (D SN 5 5.0 6 0.7 mm) and HNPP (D SN 5 5.7 6 0.7 mm) were similar to values in controls (D SN 5 5.1 6 0.6 mm). Finally, consistent with muscle pathology following denervation, varying degrees of muscle atrophy and fat infiltration were observed in patients (white arrow, figure 1) .
MTR values are reduced in patients with CMT. Representative MTR maps from a control subject and patient with CMT1A (before and after B 1 correction) are shown in figure 2. Lower MTR values were observed in the SN of the patient with CMT1A (blue hues) relative to the control subject (yellow hues). The shading in MTR prior to correction scaled in an approximately linear fashion with the B 1 values, and most of this shading was removed with the correction strategy. In addition, the B 1 correction scheme improved the interscan repeatability of MTR v (9% increase in ICC, 46% decrease in RC).
Scatterplots of MTR v vs age and BMI are given in figure 3 (top row). In the control cohort, the effects of BMI (r 2 5 0.02, p 5 0.56), age (r 2 5 0.03, p 5 0.50), and sex (r 2 5 0.05, p 5 0.34) on MTR v were not significant. Results from the single-factor analysis of variance suggested that mean MTR v values varied across cohorts (p , 0.01), and post hoc analysis detected differences between (1) control (37.2 6 2.3 pu) and CMT1A (33.8 6 3.3 pu; p 5 0.01) and (2) control and CMT2A (31.5 6 1.9 pu; p , 0.01) cohorts. MTR v values were slightly reduced in patients with HNPP (34.4 6 2.0 pu), but more data are needed to test whether this is significant.
MTR values correlate with neurologic disability in patients with CMT. Across subjects with a genetically confirmed diagnosis, a significant relationship was observed between MTR v and CMTNS C (figure 3D: r 2 5 0.41, p 5 0.01). For the leg-specific score (CMTNS L ), a stronger relationship was observed (r 2 5 0.49, p , 0.01). Within the CMT1A cohort, a trend toward significance was observed between MTR v and CMTNS C (r 2 5 0.39, p 5 0.10) and a significant relationship was observed for CMTNS L (r 2 5 0.51, p 5 0.05). In contrast, no relationship was detected between nerve size and neuropathy scores (r 2 5 0.05, p 5 0.43 for D SN and CMTNS L ) or between NCS data and neuropathy scores (r 2 5 0.06/,0.01, p 5 0.39/0.75 for MCV/CMAP and CMTNS L ). Finally, inclusion of the patients with CMT with unknown genetic cause did not significantly alter these correlations (r 2 5 0.22/0.33, p 5 0.04/0.01 for MTR and CMTNS C /CMTNS L ).
MTR values are repeatable. Sample interscan and interrater plots of MTR s are shown in figure 4 . As expected, MTR v (ICC 5 0.92, RC 5 1.3 pu) showed a higher level of repeatability and lower level of variability than MTR s (ICC 5 0.69, RC 5 3.1 pu) for the interscan data. In both cases, we did not detect a significant difference in MTR across time (p 5 0.29 for MTR s , p 5 0.70 for MTR v ). For the inter-rater data, MTR s (ICC 5 0.99, RC 5 0.8) and MTR v (ICC . 0.99, RC 5 0.2) values were nearly identical across raters. DISCUSSION This study demonstrates that (1) proximal nerve pathology can be reliably assessed by MTR and (2) the resulting MTR values correlate with disability. This latter finding supports the potential use of proximal nerve MTR measurements as a biomarker in patients with CMT; the former supports the use of these measurements in future longitudinal studies (the lower limit detection for MTR v changes is z1.5 pu). Interestingly, it appears that a relationship between proximal nerve MTR values and disability exists when looking across inherited neuropathy cohorts, including pathologically distinct cohorts such as HNPP, as well as when looking within the CMT1A cohort. In addition, the relationship between MTR and disability was strongest when confining our assessment to the legs (CMTNS L ). This suggests that MTR values in the SN specifically report on leg functions, which would be expected given that the SN is the primary conduit for motor and sensory information in the leg. In contrast, SN diameters (from MRI) and NCS-derived measures in median or ulnar nerves did not relate to disability.
One concern when examining novel MRI techniques is the confounding influence of comorbidities and demographic dispersion. Our results suggest that proximal nerve MTR values are largely independent of age, sex, and BMI. While previous work in white matter 32 has shown that MTR values vary with age, this relationship was found to be nonlinear, with values that are approximately constant over the age range studied. Interestingly, a similar relationship has been observed for diffusion metrics in nerve. 33 For MTR values of proximal nerve, additional data are needed to demonstrate whether such a relationship exists. Nevertheless, the effect of age (and BMI) on MTR was small in the current study; therefore, the observed differences are likely driven by pathologic rather than demographic factors.
Almost all conventional tests for human neuropathies target distal nerves. However, distal nerves are severely damaged in patients with CMT, producing a difficult-to-interpret floor effect when these tests are used as outcome measurements. For instance, NCS recordings on distal nerves are typically nonresponsive Representative magnetization transfer ratio maps before and after B 1 correction
Representative uncorrected magnetization transfer ratio (MTR) maps (A), relative B 1 maps (B, B 1 given as a percentage of the desired value), and B 1 -corrected MTR maps (C) from a control subject (top row) and patient with Charcot-Marie-Tooth type 1A (CMT1A) (bottom row). Slices were taken from center of the volume (at L/3 from the lower extremity as indicated in figure 1 ), and all images were masked to eliminate background voxels as well as voxels that had been partially volume averaged with fat. Note that most of the shading in the uncorrected MTR maps was removed by the B 1 correction process (the regions labeled 1, 2, and 3 in the uncorrected CMT1A map contain hues ranging from green to red, while the same regions in the corrected map contain more homogenous yellow hues). Consistent with the general trend (table), lower MTR values were observed in the sciatic nerve (zoomed inset) of the patient with CMT1A (blue hues) than the control subject (yellow hues).
in the lower limbs of patients with CMT. 24, 25 In the upper limbs, sensory nerves are also typically nonresponsive, and even motor nerves can be nonresponsive in severe cases. 25, 34 This longstanding obstacle, which limits the ability to longitudinally study CMT, may be overcome using proximal nerve MTR measurements. In addition, MTR measurements of proximal nerves may allow for insights into the neurobiology of CMT in humans-information previously available only via autopsy studies. 35 Axon-Schwann cell interactions play an important role in neurologic function 36 ; therefore, anything that disrupts these interactions (e.g., demyelination, axonal loss) leads to nerve dysfunction. Previous work in white matter has shown that myelin lipids are the dominant source of MT, 37 and additional studies in peripheral nerve 20 have demonstrated that MTR correlates with myelin density. Given that myelin density is affected by demyelination/dysmyelination and axonal loss, MTR likely reports on the combined effect of these processes and, therefore, reports on disability. In addition, other factors that affect macromolecular content, such as changes in collagen content, may also modulate the observed MTR values in the peripheral nervous system. Although promising, several limitations of this study should be addressed. First, a cross-sectional design was chosen to assess the effect of disease type, disability, and confounding variables (age, sex, and BMI) on nerve MTR values. This did not allow us to assess the sensitivity of the nerve MTR values to pathologic changes over time. Given that (1) diffusion MRI metrics of nerve have been shown to be sensitive to disease progression in other neuropathies 19 and (2) MTR and diffusion MRI probe complementary aspects of nerve pathology, 38 future longitudinal studies are needed. Second, a small number of patients were studied. Despite this limitation, a significant relationship was observed between MTR and disability in patients with genetically confirmed CMT, and inclusion of patients with CMT without genetic confirmation did not alter this relationship. Thus, it appears that the results may be indicative of the larger population of patients with inherited neuropathies. Finally, MTR is a semiquantitative measure that is also sensitive to hardware settings/experimental parameters 39 as well as T 1 relaxation times. 40 The issue of hardware settings was mitigated via a B 1 correction scheme. Furthermore, from inspection of T 1 -weighted images, it appears that T 1 values were not significantly altered in any subjects. For future multisite or longitudinal studies, however, protocol standardization or additional correction schemes 39 may be needed. In addition, quantitative MT approaches 40 should be explored, as these techniques yield parameters that are insensitive to the aforementioned issues that can affect MTR. This study demonstrates that MTR measurements of the SN correlate with clinical disability in patients with CMT. The developed imaging protocols and data analysis pipelines resulted in highly repeatable MTR measurements. These results suggest that MTR measurements of proximal nerves may be of value as a biomarker, especially given that distal nerves are often fully degenerated in patients with CMT and proximal nerves are inaccessible via conventional techniques.
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Figure 4
Representative interscan and inter-rater data
Representative interscan and inter-rater magnetization transfer ratio values calculated for each slice (MTR s ). For the interscan data, the control subjects with the smallest (A) and largest (C) root mean squared (RMS) difference across scans are given. The mean values across scans (red and dark blue lines) were repeatable at the slicewise (MTR s ) and volumetric levels (magnetization transfer ratio values calculated across the entire volume [MTR v ]); however, differences were observed in distal slices in a few subjects (see the MTR overcorrection in C, which is most likely due to artifacts in this subject's B 1 map). For the inter-rater data, the control (B) and patient (D) with the median RMS difference are given. In all cases, the mean values across raters (black and light blue lines) were highly repeatable.
